Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K141841
    Date Cleared
    2014-08-01

    (24 days)

    Product Code
    Regulation Number
    888.3045
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    INTEGRA LIFESCIENCE CORPORTATION

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Integra MOZAIK™ Osteoconductive Scaffold - Strip is intended for use as a bone void filler to fill voids or gaps of the skeletal system in the extremittes, spine, and pelvis not intrinsic to the stability of the bony structure. Integra MOZAIK™ Osteoconductive Scaffold - Strip is also indicated for use in the treatment of surgically treated osseous defects or osseous defects created from traumatic injury to the bone. Following placement in the bony void or gap (defect), Integra MOZAIKTM Osteoconductive Scaffold - Strip is resorbed and replaced with bone during the healing process.

    Device Description

    The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip is a porous resorbable bone void filler made from highly purified bovine Type I collagen and calcium salt (8-Tricalcium phosphate Ca3(PO4)2 per ASTM F1088).

    The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip bone grafting construct is designed to facilitate the repair of bony defects. The matrix has a three dimensional trabecular network of pores that resembles the pore structure of human cancellous bone. The three dimensional pore structure quickly imbibes fluids, making it easy to combine bone marrow aspirate.

    The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip guides bone regeneration across a critical defect site into which the products are implanted. New bone forms in apposition to the matrix surface when the grafts are placed in direct contact with viable host bone. Ultimately, the matrices are resorbed and remodeled into bone.

    The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip is provided sterile, nonpyrogenic, for single use in double peel packages.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study information for the Integra MOZAIK™ Osteoconductive Scaffold - Strip (5cc):

    It is important to note that the provided documents (FDA 510(k) summary) describe a substantial equivalence determination for a new size (5cc) of an existing medical device. This means the primary "study" demonstrated that the 5cc device is equivalent to a previously cleared 15cc device, rather than proving the 5cc device's de novo clinical efficacy through a traditional clinical trial with specific acceptance criteria on performance metrics like sensitivity, specificity, etc. Therefore, many of the requested fields (e.g., sample size for test set, number of experts, MRMC study, ground truth for training set) are not applicable or explicitly stated in the context of this 510(k) submission.


    Acceptance Criteria and Device Performance

    Acceptance Criteria ObjectiveAcceptance Criteria (Implicit)Reported Device Performance
    Material EquivalenceThe 5cc device should have the same materials as the predicate (15cc) device."The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip has the same materials... as the commercially marketed devices, 10cc and 15cc Integra MOZAIK™ Osteoconductive Scaffold - Strip (K063124)." It is made from "highly purified bovine Type I collagen and calcium salt (β-Tricalcium phosphate Ca3(PO4)2 per ASTM F1088)."
    Design EquivalenceThe 5cc device should have a similar design (e.g., porous resorbable bone void filler with a three-dimensional trabecular network) to the predicate device."The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip has the same... design... as the commercially marketed devices, 10cc and 15cc Integra MOZAIK™ Osteoconductive Scaffold - Strip (K063124)." It is described as a "porous resorbable bone void filler made from highly purified bovine Type I collagen and calcium salt (β-Tricalcium phosphate Ca3(PO4)2 per ASTM F1088)." The "matrix has a three dimensional trabecular network of pores that resembles the pore structure of human cancellous bone."
    Performance EquivalenceThe 5cc device should exhibit similar performance characteristics and meet specifications as the predicate device."Performance tests were conducted to demonstrate equivalence between the 5cc and 15cc Integra MOZAIK™ Osteoconductive Scaffold - Strip and to ensure that 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip meets specification." The report states: "All test results were acceptable." The 5cc device guides bone regeneration and is resorbed and remodeled into bone, consistent with the predicate. Biocompatibility and in vivo performance testing from the 15cc predicate were applied to the 5cc device.
    Intended Use EquivalenceThe 5cc device should have the same indications for use as the predicate device."The 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip has the same... intended use as the commercially marketed devices, 10cc and 15cc Integra MOZAIK™ Osteoconductive Scaffold - Strip (K063124)." The indications described are identical to those of the predicate device.
    Safety and EffectivenessThe modifications (change in size) should not raise any new issues of safety or effectiveness."The modifications expressed in this 510(k) Premarket Notification do not change the intended use or fundamental scientific technology of the device, and do not raise any new issues of safety or effectiveness."

    Study Details (as inferable from a 510(k) submission for substantial equivalence):

    1. Sample size used for the test set and the data provenance:

      • Sample Size: Not applicable in the context of a clinical test set for performance metrics like sensitivity/specificity. The "test set" here refers to the actual 5cc device being compared against the predicate.
      • Data Provenance: The document does not specify a separate "test set" derived from studies involving patients. Instead, the basis of data provenance for equivalence is likely derived from laboratory testing (mechanical, chemical, physical properties) of the 5cc device and a reliance on the existing pre-clinical and clinical data of the predicate 15cc and 10cc devices. The phrase "biocompatibility and in vivo performance testing will be applied to the 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip" suggests the previous study's data is leveraged, rather than new, separate human/animal studies for the 5cc, specifically for biocompatibility and in vivo performance.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Not applicable. Ground truth, in this context, would relate to clinical outcomes or expert diagnoses, which are not directly assessed for the 5cc device in this submission, as it relies on equivalence to a predicate. The "ground truth" for the equivalence claim is the established safety and effectiveness of the existing predicate device.
    3. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

      • Not applicable. This type of adjudication method is used in studies where multiple human readers review cases to establish a consensus ground truth for evaluating AI performance. This submission does not involve such a process.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No, a MRMC comparative effectiveness study was not done. This device is a bone void filler, not an AI diagnostic tool that assists human readers.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

      • Not applicable. This device is a physical medical implant, not an algorithm.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • The "ground truth" here is the established safety and effectiveness profile of the legally marketed predicate device (15cc Integra MOZAIK™ Osteoconductive Scaffold - Strip (K063124)). This profile would have been based on a combination of:
        • Laboratory testing (physical, chemical, mechanical properties)
        • Biocompatibility testing (in vitro and/or in vivo animal studies)
        • In vivo performance testing (animal studies demonstrating bone regeneration and resorption)
        • Potentially clinical outcomes data from the predicate's use.
      • For the 5cc device, the ground truth is its verified similarity in materials, design, and performance to this well-established predicate.
    7. The sample size for the training set:

      • Not applicable. This device is a physical product, not an AI model requiring a training set.
    8. How the ground truth for the training set was established:

      • Not applicable. As above, this device is not an AI model.

    Summary of the "Study" Proving Equivalence:

    The "study" in this context is a bench and literature-based comparative analysis as part of a 510(k) submission. Integra LifeSciences Corporation demonstrated that the 5cc Integra MOZAIK™ Osteoconductive Scaffold - Strip meets the acceptance criteria for substantial equivalence to its predicate (the 15cc Integra MOZAIK™ Osteoconductive Scaffold - Strip, K063124) by:

    • Asserting identical materials, design, performance, and intended use.
    • Conducting performance tests on the 5cc device to ensure it meets specifications, with all results being acceptable.
    • Leveraging the biocompatibility and in vivo performance testing data from the predicate device based on FDA guidance for Class II Special Controls Guidance Document: Resorbable Calcium Salt Bone Void Filler Device (June 2, 2003).

    The conclusion is that the change in size (from 15cc to 5cc) does not alter the fundamental scientific technology or raise new issues of safety or effectiveness, thus proving substantial equivalence rather than independent clinical efficacy.

    Ask a Question

    Ask a specific question about this device

    K Number
    K121159
    Date Cleared
    2012-07-20

    (95 days)

    Product Code
    Regulation Number
    882.1620
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    INTEGRA LIFESCIENCE CORPORTATION

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Use of the Integra™ Camino® Flex Ventricular Intracranial Pressure Monitoring Kit with Integra™ Camino® Flex Adapter is indicated when direct and continuous intraventricular intracranial pressure (ICP) monitoring and cerebrospinal fluid (CSF) drainage are required.

    Device Description

    The Integra™ Camino® Flex Ventricular Intracranial Pressure Monitoring Kit with Integra™ Camino® Flex Adapter functions as an entire system that includes the following: Integra Camino Flex Ventricular Catheter Monitoring Kit (Catheter and Accessories) and Integra Camino Flex Adapter (Adapter and Extension Cable), in which the Integra Camino Flex Adapter connects to the previously cleared Camino Advanced Monitor (510(k) K962928 Integra LifeSciences Corporation).

    The Integra Camino Flex Ventricular Intracranial Pressure Monitoring Kit with Integra Camino Flex Adapter is indicated when direct and continuous intraventricular intracranial pressure (ICP) monitoring and cerebrospinal fluid (CSF) drainage are required. The device is a single use, disposable product. The device is comprised of a highly flexible catheter with a tensile member, a pressure sensing tip, an electrical connection to a monitor, and a drainage lumen to allow fluid connection to an extraventricular drainage (EVD) device. The device is designed for the tunneling surgical method and the kit includes the necessary accessories for access and implantation of the catheter. The following Accessories are referenced in 510(k) K904883: Drill, Drill Stop, Set Screw, Hex Wrench, Trocar, Trocar Sheath, Suture Loops, and Male Luer Cap.

    The tip of the Integra Camino Flex Ventricular Catheter is implanted within the anterior horn of the left or right lateral cerebral ventricle. A cylindrical volume with a height of at least 11 mm and a diameter of at least 5 mm are required for catheter implantation.

    The Integra Camino Flex Adapter performs the functions of receiving the transducer signal from the Integra Camino Flex Ventricular Intracranial Pressure Monitoring Kit catheter, amplifying the signal, and transmitting the signal to the Camino® Advanced Monitor. The Integra Camino Flex Adapter converts the signals produced by the Integra Camino Flex Ventricular Intracranial Pressure Monitoring Kit catheter sensor. This signal is sent to the Adapter by means of the extension cable to the Camino® Advanced Monitor.

    AI/ML Overview

    The Integra™ Camino® Flex Ventricular Intracranial Pressure Monitoring Kit with Integra™ Camino® Flex Adapter is a medical device. The provided text describes the device and its intended use but does not contain information about acceptance criteria or a study proving its performance against such criteria. The document is a 510(k) summary for regulatory clearance, focusing on substantial equivalence to predicate devices, sterilization, and general device description.

    Therefore, I cannot provide the requested table, sample sizes, expert qualifications, adjudication methods, multi-reader multi-case study information, standalone performance, or training set details from the provided text. This information would typically be found in a detailed validation or clinical study report, which is not present here.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1